Vendas Alterar Data
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Akebia Therapeutics USD 57.62M 1.14M 2025-12
ALKERMES USD 480.13M 15.88M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amarin USD 49.22M 451K 2025-12
ANI Pharmaceuticals USD 290.77M 24.77M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Coherus Biosciences USD 12.75M 1.18M 2025-12
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Exelixis USD 658.69M 30M 2026-09
Glaxosmithkline GBP 8.89B 1.2B 2026-09
Heron Therapeutics USD 40.59M 2.38M 2025-12
Ionis Pharmaceuticals USD 243M 25M 2026-09
Ironwood Pharmaceuticals USD 113.04M 6.53M 2026-06
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Lonza CHF 3.58B 63M 2025-06
Merck USD 18.1B 1.5B 2026-09
Moderna USD 1.31M 98.69M 2026-09
Myriad Genetics USD 190.7M 9.7M 2026-06
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neurocrine Biosciences USD 1.12B 161M 2026-09
Pacira USD 176.65M 15.75M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
PTC Therapeutics USD 357.8M 3.2M 2026-09
Sanofi EUR 14.44B 2.49B 2026-09
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
United Therapeutics USD 832.5M 49.2M 2026-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12